BSE filing, NSE: SMT. Summary written from the filing by ALFA Finder's alert engine.
Sahajanand Medical Technologies Ltd: key numbers
- Share price
- ₹483.00
- Market cap
- ₹4,910 Cr
- Revenue (annual)
- ₹1,210 Cr
- Net profit (annual)
- ₹65.28 Cr
- Promoter holding
- 36.20%
- FII holding
- 35.09%Current quarter
Reference market data from a third-party provider, updated daily. Not a valuation or a recommendation.
More from Sahajanand Medical Technologies Ltd
All →Sahajanand Medical Technologies Legal & Regulatory
Sahajanand Medical Technologies received a GST DRC-01D recovery notice from Jharkhand tax authorities. The demand totals Rs. 34.29 lakh, which the company is contesting before appellate authorities.
- Value
- ₹0.34 Cr
Sahajanand Medical Technologies Credit Rating
CRISIL has upgraded Sahajanand Medical Technologies' long-term bank facility rating to CRISIL A-/Stable from BBB+/Stable. The upgrade reflects improved business risk, growing scale, and sustained profitability across its global stent manufacturing operations.
- Value
- ₹300.0 Cr
Sahajanand Medical Technologies Board Meeting Date
Sahajanand Medical Technologies scheduled a board meeting for 5 November 2026 to consider Q2 and half-year financial results. No financial figures are disclosed yet.
Sahajanand Medical Technologies Legal & Regulatory
Sahajanand Medical Technologies received a DGGI summons under GST Act Section 70 for books verification. The company says there is no material financial impact at this stage.
Sahajanand Medical Technologies Other Announcement
Sahajanand Medical Technologies disclosed its Key Managerial Personnel authorized to determine materiality under LODR Reg 30(5). The filing lists the MD & CEO, CFO, and Company Secretary with contact details.
Other capital structure change announcements
All →Arvaya Healthcare Capital Structure Change
Arvaya Healthcare's board approved the draft letter of offer for a rights issue of partly paid-up equity shares up to ₹210 Crore, plus a postal ballot. The board outcome's main decision is the rights issue, so it is classified as a capital raise step.
- Value
- ₹210.0 Cr
Mittal Life Style Capital Structure Change
Mittal Life Style set 15 December 2026 as the record date for a 10:1 consolidation of its equity shares. No cash is paid.
Zodiac JRD MKJ Capital Structure Change
Zodiac-JRD-MKJ approved final terms of its Rs 40 crore rights issue at Rs 25 per share. Issue runs 19 November to 3 December 2026.
- Value
- ₹40.00 Cr
Baba Arts Capital Structure Change
Skybridge Interactive LLP, a non-promoter acquirer, disclosed under Reg 29(2) that it acquired 65,00,000 shares of Baba Arts, raising its stake from 62.28% to 74.67%. The acquisition was off-market under a share purchase agreement dated 25 February 2026.
Dr. Lal Pathlabs Capital Structure Change
Dr. Lal PathLabs will invest up to Rs 49.5 Crore in its wholly owned Dubai subsidiary, in tranches. Funds cover operations and further investment in Ghana's SHL.
- Value
- ₹49.50 Cr
- Execution
- Indicative completion by 31 March 2027, in tranches
Atul Capital Structure Change
Atul bought back 4,100 equity shares on 4 November 2026 for ₹2.09 Crore. Cumulative buyback utilisation stands at ₹10.82 Crore of ₹90 Crore earmarked.
- Value
- ₹2.09 Cr